Study of the Clinical Impact of Surgical Correction of Tricuspid Insufficiency in Implantable LVAD Patients
Public ClinicalTrials.gov record NCT02537769. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Randomized Study of the Clinical Impact of Surgical Correction of Tricuspid Insufficiency in Implantable LVAD Patients
Study identification
- NCT ID
- NCT02537769
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 40 participants
Conditions and interventions
Interventions
- Left ventricular assist device (LVAD) Device
- Tricuspid Valve Repair (TVR) Procedure
Device · Procedure
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 31, 2015
- Primary completion
- Nov 30, 2025
- Completion
- Nov 30, 2026
- Last update posted
- Feb 22, 2021
2015 – 2026
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Washington Medical Center | Seattle | Washington | 98195 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Heart Failure NYHA Class III trials
Other public records listing Heart Failure NYHA Class III. Sorted by last update posted; newest first. Not a recommendation.
- NCT07232030: Barostim-Enabled NEurohormonal Intervention For Improving Treatment of Heart Failure Recruiting
- NCT05885607: Early Metabolic Adaptations to SGLT2 Inhibition in Heart Failure Active, not recruiting
- NCT06859970: An Early Feasibility Study Evaluation of an Implant Free Interatrial Shunt to Improve Heart Failure Active, not recruiting
- NCT04829617: Promoting Well-being and Health in Heart Failure Recruiting
- NCT05647213: Autologous Induced Pluripotent Stem Cells of Cardiac Lineage for Congenital Heart Disease Recruiting
- NCT06791850: Sustaining Home Heart Failure Palliative Care in Rural Appalachia Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02537769, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 22, 2021 · Synced May 16, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02537769 live on ClinicalTrials.gov.